Susan Brandenburg

1.5k total citations
23 papers, 1.1k citations indexed

About

Susan Brandenburg is a scholar working on Immunology, Neurology and Genetics. According to data from OpenAlex, Susan Brandenburg has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Neurology and 10 papers in Genetics. Recurrent topics in Susan Brandenburg's work include Immune cells in cancer (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Glioma Diagnosis and Treatment (10 papers). Susan Brandenburg is often cited by papers focused on Immune cells in cancer (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Glioma Diagnosis and Treatment (10 papers). Susan Brandenburg collaborates with scholars based in Germany, Italy and United States. Susan Brandenburg's co-authors include Peter Vajkoczy, Kati Turkowski, Annett Müller, Irina Kremenetskaia, Alexander D. Bungert, Anne Blank, Güliz Acker, Susanne Müller, Frank L. Heppner and Ulf C. Schneider and has published in prestigious journals such as Proceedings of the National Academy of Sciences, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Susan Brandenburg

22 papers receiving 1.1k citations

Peers

Countries citing papers authored by Susan Brandenburg

Since Specialization

Citations

This map shows the geographic impact of Susan Brandenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Brandenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Brandenburg more than expected).

Fields of papers citing papers by Susan Brandenburg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Brandenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Brandenburg. The network helps show where Susan Brandenburg may publish in the future.

Co-authorship network of co-authors of Susan Brandenburg

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Brandenburg. A scholar is included among the top collaborators of Susan Brandenburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Brandenburg. Susan Brandenburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Determinants of cerebral radionecrosis in animal models: A systematic review 2024 ·Radiotherapy and Oncology ·(unknown), Carolin Senger, (unknown), (unknown), (unknown), (unknown), Melina Nieminen-Kelhä, Susan Brandenburg, Daniel Zips, Peter Vajkoczy, Güliz Acker	0
2	In vivo characterization of brain tumor biomechanics: magnetic resonance elastography in intracranial B16 melanoma and GL261 glioma mouse models 2024 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Ingolf Sack, Carolin Senger, Melina Nieminen-Kelhä, Susan Brandenburg, (unknown), (unknown), (unknown), (unknown), Stefan Koch, Philipp Boehm‐Sturm, Rolf Reiter, Daniel Zips, Peter Vajkoczy, Güliz Acker	2
3	CD13 expression affects glioma patient survival and influences key functions of human glioblastoma cell lines in vitro 2024 ·BMC Cancer ·Wenying Zhang, Anne Blank, Irina Kremenetskaia, Anja Nitzsche, Güliz Acker, Peter Vajkoczy, Susan Brandenburg	3
4	Myeloid cell subpopulations compensate each other for Ccr2‐deficiency in glioblastoma 2022 ·Neuropathology and Applied Neurobiology ·Alexander D. Bungert, (unknown), (unknown), (unknown), Susanne Mueller, Annett Mueller, Matthäus Felsenstein, (unknown), Anne Blank, Adnan Ghori, Philipp Boehm‐Sturm, Stefan Koch, Peter Vajkoczy, Susan Brandenburg	5
5	Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro 2022 ·Oncology Reports ·(unknown), (unknown), Peter Vajkoczy, Susan Brandenburg, Güliz Acker	7
6	Establishment and Validation of CyberKnife Irradiation in a Syngeneic Glioblastoma Mouse Model 2021 ·Cancers ·(unknown), Carolin Senger, Anne Kluge, (unknown), Melina Nieminen-Kelhä, Irina Kremenetskaia, Susanne Mueller, Susan Brandenburg, Franziska Loebel, Ingeborg Tinhofer, Alfredo Conti, Volker Budach, Peter Vajkoczy, Güliz Acker	5
7	Optical Characterization of Sodium Fluorescein In Vitro and Ex Vivo 2021 ·Frontiers in Oncology ·Ran Xu, (unknown), Florian Frenzel, Katrin Hoffmann, Josefine Radke, Judith Rösler, Katharina Faust, Anne Blank, Susan Brandenburg, Martin Misch, Peter Vajkoczy, Julia Onken, Ute Resch‐Genger	5
8	Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH) 2021 ·Journal of Neuroinflammation ·(unknown), Susan Brandenburg, Melina Nieminen-Kelhä, Irina Kremenetskaia, Philipp Boehm‐Sturm, Peter Vajkoczy, Ulf C. Schneider	61
9	Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), Susan Brandenburg, Melina Nieminen-Kelhä, Irina Kremenetskaia, (unknown), Susanne Mueller, Kerstin Rubarth, Arend Koch, Peter Vajkoczy, Güliz Acker	24
10	The CXCL2/IL8/CXCR2 Pathway Is Relevant for Brain Tumor Malignancy and Endothelial Cell Function 2021 ·International Journal of Molecular Sciences ·(unknown), Anne Blank, Irina Kremenetskaia, Peter Vajkoczy, Güliz Acker, Susan Brandenburg	34
11	Advances in Chemokine Signaling Pathways as Therapeutic Targets in Glioblastoma 2021 ·Cancers ·(unknown), Peter Vajkoczy, Susan Brandenburg	47
12	CCR2 of Tumor Microenvironmental Cells Is a Relevant Modulator of Glioma Biology 2020 ·Cancers ·Matthäus Felsenstein, Anne Blank, Alexander D. Bungert, Annett Mueller, Adnan Ghori, Irina Kremenetskaia, (unknown), Thomas Broggini, Kati Turkowski, Lea Scherschinski, (unknown), Peter Vajkoczy, Susan Brandenburg	24
13	The CXCR2/CXCL2 signalling pathway – An alternative therapeutic approach in high-grade glioma 2020 ·European Journal of Cancer ·Güliz Acker, (unknown), (unknown), Melina Nieminen-Kelhä, Irina Kremenetskaia, Susanne Mueller, Adnan Ghori, Peter Vajkoczy, Susan Brandenburg	37
14	Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma 2017 ·Immunologic Research ·Susan Brandenburg, Kati Turkowski, Annett Mueller, (unknown), (unknown), Peter Vajkoczy	28
15	VEGF as a modulator of the innate immune response in glioblastoma 2017 ·Glia ·Kati Turkowski, Susan Brandenburg, Annett Mueller, Irina Kremenetskaia, Alexander D. Bungert, Anne Blank, Matthäus Felsenstein, Peter Vajkoczy	57
16	Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors 2015 ·Acta Neuropathologica ·Susan Brandenburg, Annett Müller, Kati Turkowski, (unknown), (unknown), Christin Schmidt, Alexander D. Bungert, Güliz Acker, Anne Schorr, Andreas Hippe, (unknown), Frank L. Heppner, Bernhard Homey, Peter Vajkoczy	163
17	Microglia inflict delayed brain injury after subarachnoid hemorrhage 2015 ·Acta Neuropathologica ·Ulf C. Schneider, (unknown), Susan Brandenburg, Annett Müller, (unknown), Salima Magrini, (unknown), Kati Turkowski, Tobias Finger, Angelika Gutenberg, (unknown), Wolfgang Brück, Frank L. Heppner, Peter Vajkoczy	115
18	Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells 2014 ·International Journal of Cancer ·Annett Müller, Susan Brandenburg, Kati Turkowski, Susanne Müller, Peter Vajkoczy	139
19	Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus 2009 ·Proceedings of the National Academy of Sciences ·Jens Y. Humrich, (unknown), Reinmar Undeutsch, Philipp Enghard, (unknown), (unknown), Lutz Kloke, (unknown), Timo Gaber, Susan Brandenburg, Alexander Scheffold, Jochen Huehn, Andreas Radbruch, Gerd‐Rüdiger Burmester, Gabriela Riemekasten	148
20	IL‐2 induces in vivo suppression by CD4⁺CD25⁺Foxp3⁺ regulatory T cells 2008 ·European Journal of Immunology ·Susan Brandenburg, Takeshi Takahashi, Maurus de la Rosa, Marko Janke, (unknown), (unknown), Zane Orinska, Silvia Bulfone‐Paus, Alexander Scheffold	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact